je.st
news
Bio-Path Holdings Reports Third Quarter 2014 Operational and Financial Results
2014-11-18 11:35:59| Semiconductors - Topix.net
Bio-Path Holdings, Inc., , a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the third quarter ended September 30, 2014. The final patient of cohort six completed treatment in the Phase I clinical trial evaluating Bio-Path's lead product candidate, BP-100-1.01 in blood cancers.
Tags: results
reports
financial
quarter
Category:Electronics and Electrical
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||